XM does not provide services to residents of the United States of America.
E
E

Easyjet

Technical Summary

IndicatorValueTrend
IndicatorValueTrend
IndicatorValueTrend
IndicatorS3S2S1PR1R2R3

News

UK corporate earnings week ahead

DIARY-UK corporate earnings week ahead Nov 22 (Reuters) - Diary of U.K (.FTSE) corporate earnings for the week ahead UK EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 26-Nov-2024 NTS LMPL.L LondonMetric Property PLC Half Year 2025 LondonMetric Property PLC Earnings Release 26-Nov-2024 07:00 CPG.L Compass Group PLC Full Year 2024 Compass Group PLC Earnings Release 27-Nov-2024 BMO EZJ.L Easyjet PLC Full Year 2024 Easyjet PLC Earnings Release ** All times are listed in BMO - 'Befo
C
E
U

Europe's STOXX 600 corporate earnings week ahead

DIARY-Europe's STOXX 600 corporate earnings week ahead Nov 22 (Reuters) - Diary of Europe's STOXX 600 (.STOXX) corporate earnings for the week ahead EUROPE'S STOXX 600 EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 26-Nov-2024 NTS LMPL.L LondonMetric Property PLC Half Year 2025 LondonMetric Property PLC Earnings Release 26-Nov-2024 NTS CDR.WA CD Projekt SA Q3 2024 CD Projekt SA Earnings Release 26-Nov-2024 09:15 LMPL.L LondonMetric Property PLC Half Year 2025 LondonMetric Prope
C
E
E
P
J

Spain fines Ryanair, others $187 mln over cabin bag fees

UPDATE 2-Spain fines Ryanair, others $187 mln over cabin bag fees Consumer rights ministry rejects appeals against fines Ryanair fined 108 mln euros, Vueling 39 mln euros Ryanair says it will take its appeal to Spain's courts Adds comments from Ryanair's CEO and details MADRID, Nov 22 (Reuters) - Spain's consumer rights ministry has fined budget airlines including Ryanair RYA.I and Vueling a combined 179 million euros ($187 million) for practices such as charging for larger cabin bags, it said o
E

UK Stocks-Factors to watch on Nov 22

UPDATE 1-UK Stocks-Factors to watch on Nov 22 Adds new items, updates futures Nov 22 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening higher on Friday, with futures FFIc1 up 0.6%. * GSK: GSK GSK.L said that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in adults aged between 50 and 59, who are at increased risk of severe RSV disease.
B
E
G

Ryanair, Easyjet and others fined $187 mln for cabin luggage fees

Ryanair, Easyjet and others fined $187 mln for cabin luggage fees MADRID, Nov 22 (Reuters) - Spain's Consumer Rights Ministry said on Friday it fined on budget airlines Ryanair RYA.I , easyJet EZL.L , Vueling ICAG.L , Norwegian NAS.OL and Volotea a combined 179 million euros ($187.61 million) for practices such as charging for cabin luggage. The ministry upheld the fines that were announced in May and dismissed the appeals lodged by companies.
E

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.